References
- Reid J. L. Hypertension and stroke: opportunities for prevention and prospects for protection. J Hypertens. 1993; II(suppl 5)S2–S6
- Graham D. I. Vascular and hypoxic disorders. ‘An introduction to renin pathology’, J. Hume Adams, D. I. Graham. Churchill Livingstone, Edinburgh 1988; 57–82
- McCulloch J. Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage. Br J Clin Pharmacol. 1992; 34: 106–114
- Lees K. R. Therapeutic preventions in acute stroke. Br J Clin Pharmacol. 1992; 34: 486–493
- Tamura A., Graham D. I., McCulloch J., Teasdale G. Focal central ischaemia in the rat: description of the technique and early neurological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1981; 1: 53–60
- Yamori Y., Horie R., Handa H., Sato M., Fukase M. Pathogenic similarity of strokes in stroke prone spontaneously hypertensive rats and humans. Stroke 1976; 7: 46–53
- Robinson M. J., Macrae I. M., Todd M., Reid J. L., McCulloch J. Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neuroscience Letters 1990; 118: 269–272
- Macrae I. M., Robinson M. J, Graham D. I, Reid J. L., McCulloch J. Endothelin 1 induced reductions in cerebral blood flow: dose, dependency time course and neuropathological consequences. J. Cerebral Blood Flow & Metabolism. 1993; 13: 276–284
- Dawson D. A., McCulloch J., Graham D. I, Macrae I. M. Recovery from anaesthesia improves outcome following transient but not permanent focal cerebral ischaemia in the rat. Soc. Neurosci. 1993; 18: 1654, Abstr
- Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–415
- Yoshimoto S., Ishizaki Y, Kurihara H., Sasaki T., Yoshizumi M., Yanagisawa M., Yazaki Y, Masaki T., Takakura Murota K. S. Cerebral microvessel endothelium is producing endothelin. Brain Res. 1990; 508: 283–285
- Giaid A., Gibson J. J., Ibrahim N. B.N., Legon S., Bloom S. R., Yanagisawa M., Masaki T., Vaindell I. M., Polak J. M. Endothelin 1, an endothelium derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Nat Acad Sci, U.S.A. 1989; 86: 7634–7638
- Davenport A. P., Morton A. J. Binding sites for 125I-ET-1, ET-2, ET-3 and vasoactive intestinal contractor are present in the adult rat brain and neuron enriched primary cultures of embryonic brain. Brain Res. 1991; 554: 278–285
- Macrae I. M., Robinson M. J., McAuley M. A., McCulloch J. Effects of intracisternal endothelin-1 injection on blood flow to the lower brain stem. Europ J Pharmacol. 1991; 203: 85–91
- Macrae I. M., McAuley M. A., Robinson M. J., Reid J. L., McCulloch J. Endothelin 1 induced hypertension: a consequence of medullary ischaemia. J Cardiovasc Pharmacol. 1991; 17(suppl 7)S496–499
- Macrae I. M., Dawson D. A., Mackay K. B., Graham D. I., McCulloch J. Comparison of infarct size and degree of swelling in permanent and reversible acute focal cerebral ischaemia. J Cereb Blood Flow Metab 1993; 13: S1, S94
- Dawson D. A., Graham D. I., McCulloch J., Macrae I. M. Evolution of ischaemic damage in a new model of focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1993; 13: S1, S461